Research chemicalStimulantResearch chemicalPiperazine
DBZP
Also known as DBZP · 1,4-Dibenzylpiperazine
DBZP (1,4-dibenzylpiperazine) is a minor piperazine that appears mainly as a synthesis by-product and adulterant in BZP-based party pills. It is a weak stimulant with almost no dedicated human data.
01 Overview
DBZP (1,4-dibenzylpiperazine) is rarely encountered as a stand-alone drug. It arises chiefly as an impurity or by-product of BZP synthesis and has been detected as an adulterant in seized party pills.
Its pharmacology is poorly studied, but it is presumed to share weak stimulant properties with other piperazines while being less potent. Human data is essentially absent, and its risk profile is inferred rather than characterised.
02 Mechanism
Presumed weak monoamine releaser and reuptake inhibitor analogous to BZP, but with limited direct pharmacological study.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common | 100–200 mg | Oral | Speculative range; usually encountered as an adulterant rather than dosed deliberately. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Mild stimulationPresumed weak stimulant effect based on structural similarity to BZP. | Unconfirmed |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Presumed stimulant strainCardiovascular and CNS stimulation is presumed by analogy to BZP but not documented. | Moderate | Unknown | Unconfirmed | |
| Unknown toxicity as adulterantIts main real-world exposure is as an unlabelled by-product, so dose and purity are unpredictable. | Moderate | Unknown | Unconfirmed |
06 Legal status
UK
Class C (Misuse of Drugs Act)
Captured as a piperazine derivative. · as of Jan 2026
United States
Analogue exposure possible
Not explicitly scheduled but may fall under analogue provisions. · as of Jan 2026
07 References
Dibenzylpiperazine detection in party pillsPubMed
Piperazine derivatives drug profileEUDA (European Union Drugs Agency)
08 Discussion0 comments
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.